Christopher Davis
Clipper Fund
Christopher Davis Cigna Corp stake
total: 58
Clipper Fund CI trades
- Total transactions:
- 14
- New positions:
- 1
- Added:
- 3
- Reduced:
- 10
- Held since:
- 2020 Q4
- Held for:
- 22 quarters
- Latest activity:
- 2026 Q1
According to 2026 Q1 report, Christopher Davis holds 129,690 Cigna Corp (CI) shares with a market value of roughly $34.59M accounting for 2.59% of the overall portfolio. To date, the estimated cost basis is nearly $224.31 for "buy" trades and estimated average "sell" price is $325.7. Clipper Fund first purchased CI in 2020 Q4, initially acquiring 28,320 shares. Since the initial investment in Cigna Corp (CI), Clipper Fund has made 13 more transactions.
When did Christopher Davis buy Cigna Corp (CI)?
Christopher Davis first invested in Cigna Corp (CI) in 2020 Q4 at the reported quarter-end price of $208.18 per share.
What's the cost basis of Clipper Fund's CI stake?
The estimated cost basis for Cigna Corp (CI) stake is around $224.31 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $224.31
- Weighted AVG sell price:
- $325.70
Christopher Davis's historical trades in Cigna Corp
14 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
2.59%
|
129,690
|
$266.75
|
$34,594,808
|
+235.46% (+91,030)
|
+1.82%
|
|
2025 Q2
|
1.06%
|
38,660
|
$330.58
|
$12,780,223
|
-66.94% (-78,290)
|
-2.25%
|
|
2024 Q2
|
3.34%
|
116,950
|
$330.57
|
$38,660,162
|
-0.92% (-1,080)
|
-0.03%
|
|
2024 Q1
|
3.64%
|
118,030
|
$363.19
|
$42,867,316
|
-0.77% (-920)
|
-0.03%
|
|
2023 Q4
|
3.34%
|
118,950
|
$299.45
|
$35,619,578
|
-3.21% (-3,940)
|
-0.12%
|
|
2023 Q3
|
3.65%
|
122,890
|
$286.07
|
$35,155,142
|
-0.96% (-1,190)
|
-0.03%
|
|
2023 Q1
|
3.50%
|
124,080
|
$255.53
|
$31,706,162
|
-0.62% (-780)
|
-0.02%
|
|
2022 Q4
|
4.70%
|
124,860
|
$331.34
|
$41,371,112
|
-32.57% (-60,310)
|
-2.42%
|
|
2022 Q3
|
6.22%
|
185,170
|
$277.47
|
$51,379,120
|
-3.40% (-6,510)
|
-0.2%
|
|
2022 Q2
|
5.49%
|
191,680
|
$263.52
|
$50,511,514
|
-1.22% (-2,370)
|
-0.06%
|
|
2022 Q1
|
4.13%
|
$239.61
|
-0.57% (-1,110)
|
|||
|
2021 Q3
|
3.29%
|
$200.16
|
+350.51% (+151,840)
|
|||
|
2021 Q1
|
0.88%
|
$241.74
|
+52.97% (+15,000)
|
|||
|
2020 Q4
|
0.54%
|
$208.18
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.